NEW YORK (GenomeWeb) – Molecular diagnostics company DiaCarta announced today that it has received a $300,000 Phase I Small Business Innovation Research contract from the National Cancer Institute to develop its RadTox QuantiDNA diagnostic into a commercial test for monitoring radiation response in cancer patients.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.